Banter and general comments, page-27402

Promised to stay away, but, time-line to nameplate production spod output from now to Q1 24. DMS plant commissioned, processing spodumene ramping up month on month. Binding contracts are being fulfilled July, Q3 23 onwards. 13,000 Tons outstanding planned shipment end of July 23, no doubt the company will outperform this forecasted date, earlier shipment extremley plausible IMHO as the company done so in the past, proven time-lines.

State street short-term has impacted the SP in conjunction with Goldman Sachs under valuation, this narrative will change on the basis of our company current revenue streams online, exploration growth / LOM, no company debt, no requirement for a CR.

Approx CXO 1.8 billion shares, PLS 2.8 billion, CXO 1/4 of PLS resource to date, CXO will re-rate to $2.00 plus, as always patience, wait and watch mode, no need to panic, remember there's only 1 CXO in their stage in mine time-line to ramping up production!?!

So undervalued but ticking off all company target's.

To much negative feedback on HC CXO forum, lol.

)))